Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
The Indian pharmaceutical market will treble to $20 billion from $7.1 billion (2007 figure) by 2015, with a compounded annual growth rate (CAGR) of 12.3 per cent. A report by the Federation of Indian Chambers of Commerce and Industry (Ficci) with Ernst and Young (E&Y;) states that India could be …
THE increasing population of higher-income group in the country will open a potential $ 8-billion market for multinational companies selling costly drugs, including patented products, by 2015, a Ficci-Ernst & Young study said. Besides, the report says the domestic pharmaceutical market is expected to touch $20 billion by 2015 from …
Sept. 18: Drug maker Natco Pharma on Friday said it has launched anti-swine flu drug Natflu. "Natco Pharma has launched Natflu capsule, the cure for swine flu," the Hyderabad-based firm said in a statement. The maximum retail price for the medicine is fixed at Rs 480 for a bottle of …
While H1N1 vaccine has got regulatory approval abroad, Indian vaccine manufacturers are likely to start animal testing by the end of this month. Dates were finalised after government gave Rs 10 crore each to three vaccine manufacturers
The US Food and Drug Administration Wednesday approved the H1N1 influenza vaccine from four different manufacturers, clearing the way for the vaccine to be administered as soon as enough of it is available in that country. But authorities in India said there is still some time before a vaccine is …
In Talks With GlaxoSmithKline, Pfizer & Novartis Mohit Bhalla ET NOW WOCKHARDT, a troubled drugmaker with huge debts, is in talks with GlaxoSmithKline, Pfizer and Novartis to sign a deal that would give marketing and research rights of its diabetes drugs under development to one of the global companies, two …
GLAXOSMITHKLINE (GSK) and Roche, the two original drugmakers of swine flu drugs, have said they have no immediate plans to launch their drugs in the Indian retail market as priority is to supply to governments globally. This leaves five Indian generic companies
Khomba Singh NEW DELHI FROM Tuesday, the US Food and Drug Administration (FDA) will halve the grace period it extends to drug makers globally who are found wanting in maintaining production standards and fast track actions against violators and exoneration of those who take prompt corrective measures. India has the …
Shimla: The State-level Single Window Clearance and Monitoring Authority cleared 13 new industrial projects and five expansion proposals involving an investment of Rs 330 crore and having a potential to create employment for 2,017 persons. The main projects included second unit of Reddy
A total of 10.5 lakh Oseltamivir capsules are being supplied across the country for the treatment of the swine flow affected patients. One and a half lakh swine infected patients can be treated with this volume of supply, said SM Alamgir Hossain, Virologist of Institute of Epidemiology, Disease Control and …
The World Health Organisation will provide all necessary assistance to Bangladesh in preventing the spread of swine flu virus. The assurance came when Executive Director of WHO Margaret Chan paid a call on Prime Minister Sheikh Hasina at her suite at Hotel Kempinski here Thursday afternoon (local time). Briefing the …
Opium cultivation in Afghanistan fell by 22 percent this year as prices for the drug tumbled causing farmers to switch to other crops, the United Nations said on Wednesday. Some 1.6 million Afghans, or 6.4 percent of the population, are involved in the illegal drugs trade compared to 2.4 million …
New Delhi: India will vaccinate 20 lakh healthcare and emergency services personnel against the deadly H1N1 virus by the end of January using an imported swine flu vaccine. The health ministry has set aside Rs 100 crore as an interim budget to purchase these vaccines from any one of the …
